Status:
COMPLETED
CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders
Lead Sponsor:
Arkin
Collaborating Sponsors:
Fonds NutsOhra
Conditions:
Attention Deficit Hyperactivity Disorder
Substance Use Disorders
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.
Detailed Description
Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated 23%, and ADHD...
Eligibility Criteria
Inclusion
- substance use disorder
- ADHD
- able to comply with study activities
Exclusion
- severe neurological or psychiatric diseases (for example Parkinson, dementia, psychosis, bipolar depression) which require medication
- unable to read or write Dutch language
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT01431235
Start Date
August 1 2011
End Date
December 1 2016
Last Update
January 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkin
Amsterdam, Netherlands